myrtenal has been researched along with Metastase in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antunes, F; Arruda, RF; Costa, GA; de Carvalho, ECQ; de Freitas, WR; de Souza, SB; Façanha, AR; Jerdy, H; Kanashiro, MM; Martinez-Zaguilan, R; Martins, BX; Okorokova-Façanha, AL; Sant'Anna, NF; Santos, JM; Souad, S | 1 |
1 other study(ies) available for myrtenal and Metastase
Article | Year |
---|---|
Myrtenal-induced V-ATPase inhibition - A toxicity mechanism behind tumor cell death and suppressed migration and invasion in melanoma.
Topics: Animals; Antineoplastic Agents; Bicyclic Monoterpenes; Cell Death; Cell Line, Tumor; Cell Membrane; Cell Movement; Disease Models, Animal; Drug Resistance, Neoplasm; Electrodes; Humans; Hydrogen-Ion Concentration; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; Protons; Skin Neoplasms; Terpenes; Vacuolar Proton-Translocating ATPases | 2019 |